- call +1-201-465-4211
- email sales@mrinsights.biz
Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
Scope of the Report:
This report studies the Necrotising Enterocolitis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Necrotising Enterocolitis market by product type and applications/end industries.
Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.
The global Necrotising Enterocolitis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Necrotising Enterocolitis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GlaxoSmithKline
Pfizer
Eli Lilly And Company
Bayer HealthCare
Becton, Dickinson And Company
Bristol-Myers Squibb Company
Medtronic
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Stage I
Stage II
Stage III
Market Segment by Applications, can be divided into
Hospitals & Clinics
Ambulatory Surgical Center
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Necrotising Enterocolitis Market Overview
1.1 Product Overview and Scope of Necrotising Enterocolitis
1.2 Classification of Necrotising Enterocolitis by Types
1.2.1 Global Necrotising Enterocolitis Revenue Comparison by Types (2017-2023)
1.2.2 Global Necrotising Enterocolitis Revenue Market Share by Types in 2017
1.2.3 Stage I
1.2.4 Stage II
1.2.5 Stage III
1.3 Global Necrotising Enterocolitis Market by Application
1.3.1 Global Necrotising Enterocolitis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Global Necrotising Enterocolitis Market by Regions
1.4.1 Global Necrotising Enterocolitis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Necrotising Enterocolitis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Necrotising Enterocolitis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Necrotising Enterocolitis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Necrotising Enterocolitis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Necrotising Enterocolitis Status and Prospect (2013-2023)
1.5 Global Market Size of Necrotising Enterocolitis (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Necrotising Enterocolitis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Necrotising Enterocolitis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly And Company
2.3.1 Business Overview
2.3.2 Necrotising Enterocolitis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly And Company Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer HealthCare
2.4.1 Business Overview
2.4.2 Necrotising Enterocolitis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer HealthCare Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Becton, Dickinson And Company
2.5.1 Business Overview
2.5.2 Necrotising Enterocolitis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Becton, Dickinson And Company Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb Company
2.6.1 Business Overview
2.6.2 Necrotising Enterocolitis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Company Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Medtronic
2.7.1 Business Overview
2.7.2 Necrotising Enterocolitis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medtronic Necrotising Enterocolitis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Necrotising Enterocolitis Market Competition, by Players
3.1 Global Necrotising Enterocolitis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Necrotising Enterocolitis Players Market Share
3.2.2 Top 10 Necrotising Enterocolitis Players Market Share
3.3 Market Competition Trend
4 Global Necrotising Enterocolitis Market Size by Regions
4.1 Global Necrotising Enterocolitis Revenue and Market Share by Regions
4.2 North America Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
4.3 Europe Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
4.5 South America Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
5 North America Necrotising Enterocolitis Revenue by Countries
5.1 North America Necrotising Enterocolitis Revenue by Countries (2013-2018)
5.2 USA Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
5.3 Canada Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
5.4 Mexico Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
6 Europe Necrotising Enterocolitis Revenue by Countries
6.1 Europe Necrotising Enterocolitis Revenue by Countries (2013-2018)
6.2 Germany Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
6.3 UK Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
6.4 France Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
6.5 Russia Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
6.6 Italy Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Necrotising Enterocolitis Revenue by Countries
7.1 Asia-Pacific Necrotising Enterocolitis Revenue by Countries (2013-2018)
7.2 China Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
7.3 Japan Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
7.4 Korea Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
7.5 India Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
8 South America Necrotising Enterocolitis Revenue by Countries
8.1 South America Necrotising Enterocolitis Revenue by Countries (2013-2018)
8.2 Brazil Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
8.3 Argentina Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
8.4 Colombia Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Necrotising Enterocolitis by Countries
9.1 Middle East and Africa Necrotising Enterocolitis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
9.3 UAE Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
9.4 Egypt Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
9.6 South Africa Necrotising Enterocolitis Revenue and Growth Rate (2013-2018)
10 Global Necrotising Enterocolitis Market Segment by Type
10.1 Global Necrotising Enterocolitis Revenue and Market Share by Type (2013-2018)
10.2 Global Necrotising Enterocolitis Market Forecast by Type (2018-2023)
10.3 Stage I Revenue Growth Rate (2013-2023)
10.4 Stage II Revenue Growth Rate (2013-2023)
10.5 Stage III Revenue Growth Rate (2013-2023)
11 Global Necrotising Enterocolitis Market Segment by Application
11.1 Global Necrotising Enterocolitis Revenue Market Share by Application (2013-2018)
11.2 Necrotising Enterocolitis Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Center Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Necrotising Enterocolitis Market Size Forecast (2018-2023)
12.1 Global Necrotising Enterocolitis Market Size Forecast (2018-2023)
12.2 Global Necrotising Enterocolitis Market Forecast by Regions (2018-2023)
12.3 North America Necrotising Enterocolitis Revenue Market Forecast (2018-2023)
12.4 Europe Necrotising Enterocolitis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Necrotising Enterocolitis Revenue Market Forecast (2018-2023)
12.6 South America Necrotising Enterocolitis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Necrotising Enterocolitis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Necrotising Enterocolitis Picture
Table Product Specifications of Necrotising Enterocolitis
Table Global Necrotising Enterocolitis and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
